WAY-SEC-579: A novel 5-HT3 receptor antagonist

CNS Drug Reviews

Volumn 2, Issue 3, 1996, Pages 269-293

  Middlefell, Vicki C ^a   Bill, David J ^a,b   Brammer, Neil T ^a   Coleman, James ^a   Fletcher, Allan ^a   Hallett, Ian ^a   Rhodes, Keith F ^a   Wainwright, Tracey L ^a   Ward, Terence J ^a  

^a Wyeth Research (UK) Limited   (United Kingdom)

^b PFIZER INC   (United States)

Author keywords

5 HT3 receptor antagonist; Anxiolytic; Bezold Jarisch reflex; Guinea pig ileum; Mouse light:dark box; Rat vagus; WAY SEC 579

Indexed keywords

SEROTONIN 3 ANTAGONIST; UNCLASSIFIED DRUG; WAY SEC 579;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG ACTIVITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SCREENING; GUINEA PIG; LIGHT DARK CYCLE; NONHUMAN; RAT; SEROTONINERGIC SYSTEM; TOXICITY TESTING;

EID: 0029855480     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.1996.tb00302.x     Document Type: Article

References (51)

1. Adams PR and Brown DA Action of γ-aminobutyric acid (GABA) on rat sympathetic ganglion cells. Br J Pharmacol 1973;47:639-640P.
2. 3 receptor ligands following chronic diazepam treatment? Psychopharmacology 1992;108:333-337.
3. 3 binding sites in rat entorhinal cortex. Br J Pharmacol 1988a;94:391P.
4. 3H]zacopride. J Pharm Pharmacol 1988b;40:668.
5. 3 receptor antagonist, in two animal models of anxiety. Eur J Pharmacol 1992;218:327-334.
6. 3 antagonism in the mouse. Br J Pharmacol 1991;104:250P.
7. Bill DJ, Coleman J, Hallett I, Middlefell VC, Rhodes KF, Fletcher A. The enantiomers of zacopride an intra-species comparison of their potencies in functional and anxiolytic models. Br J Pharmacol 1995;115:775-780.
8. 3 receptor antagonist, WAY-100579, mimics the acute effects of diazepam in a mouse anxiety model and prevents diazepam withdrawal anxiogenesis. Br J Pharmacol 1994;113:138P.
9. Bradley PB, Engel G, Fenuik W, et al. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytrypramine. Neuropharmacology 1986;25:563-576.
10. Bucheit KH, Engel G, Mutchler E, Richardson DP. Study of contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea pig ileum. Nauyn-Schmiedeberg's Arch Pharmacol 1985;329:36-41.
11. 3 receptors mediate depolarization of the guinea-pig isolated vagus nerve. Br J Pharmacol 1989;96:269P.
12. 3 receptors. Br J Pharmacol 1988;94:397-412.
13. 4 receptor: Naughty but nice. Trends Pharmacol Sci 1989;10:385-386.
14. 3 receptor antagonist that appears non-competitive in studies in the rat isolated vagus nerve. Br J Pharmacol 1994;113:136P.
15. Costall B, Jones BJ, Kelly ME, Naylor RJ, Tomkins DM. Exploration of mice in a black and white box: Validation as a model of anxiety. Pharmacol Biochem Behav 1989;32:777-785.
16. 3 receptors. Pharmacol Ther 1990;47:181.
17. 3 Antagonists, and Benzodiazepines. Their Comparative Behavioural Pharmacology. John Wiley and Sons Ltd., 1991:133-157.
18. Costall B, Jones BJ, Kelly ME, et al. The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam. Pharmacol Biochem Behav 1989;34:789-778.
19. Costall B, Jones BJ, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB. Sites of action of ondansetron to inhibit withdrawal from drugs of abuse. Pharmacol Biochem Behav 1990;36:97-104.
20. Crawley JN. Neuropharmacological specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav 1961;15;695.
21. 3 receptors are ion channels. Nature 1969;339:706-709.
22. DeLean A, Munson RJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978;235:E97-102.
23. Donatch P, Engel G, Richardson BP, Stadler P. ICS-205930: A highly selective and potent antagonist at peripheral neuronal 5-hydroxytryptamine (5-HT) receptors. Br J Pharmacol 1984;81:34P.
24. File SE, Andrews N. Enhanced anxiolytic effect of zacopride enantiomers in diazepam-withdrawn rats. Eur J Pharmacol 1998;237:127-130.
25. 3 receptors. In: Saxena PR, Wallis DI, Wouters W, Bevan P, eds. Cardiovascular Pharmacology of 5-Hydroxytryptamine. Dordrecht: Kluwer Academic Publishers, 1990;101-115.
26. Fozard JR. MDL 72222: A potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Nauyn-Schmiedeberg's Arch Pharmacol 1984;326:36-44.
27. Gaddum JH, Picarelli ZP. Two kinds of tryptamine receptor. Br J Pharmac Chemother 1957;12:323-328.
28. Glenn BD, Green SE. Anxiolytic profile of GR-38082F in the potentiated startle paradigm. Behav Pharmacol 1989;1; 1.
29. 3 antagonist ondansetron on benzodiazepine-induced operant behavioural dependence in rats. Psychopharmacology 1992;109:461-465.
30. 3 receptor antagonists on behavioral measures of naloxone-precipitated opioid withdrawal. Psychopharmacology 1991;105:322-328.
31. Ireland SI, Tyers MB. Pharmacological characterisation of 5-hydroxytryptamine-induced depolarisation of the rat isolated vagus nerve. Br J Pharmacol 1987;90:229-236.
32. Irwin S. Drug screening and evaluation of new compounds in animals. In: Nodine, Siegler, eds. Animal and Clinical Pharmacologic Techniques. Chicago: Year Book Med Pub, 1964:36-54.
33. 3-receptor antagonist. Br J Pharmacol 1988;93:985-993.
34. 3 Receptor antagonists in anxiety In: King FD, Jones BJ, Sanger GJ, eds. 5-Hydroxytryplamine-3 Receptor Antagonists. Boca Raton: CRC Press, 1994:183-202.
35. 3 receptor antagonist. Br J Pharmacol 1992:105:173P.
36. 3H]GR-65630 to rat area postrema, vagus nerve, and the brains of several species. Eur J Pharmacol 1989;159:157-164.
37. 3 receptors in rat brain using radioligand binding. Nature 1987;330:748-748.
38. Lader MH. Ondansetron in the treatment of anxiety. In: Racagni G et al. Biological Psychiatry (Proceedings of the 51st World Congress of Biological Psychiatry, Florence) 1991;2:885-887.
39. 3-like receptors in the rat and the guinea pig. Br J Pharmacol 1989;96:270P.
40. 3 receptors in anxiety disorders. J Psychopharm 1990.
41. Lecrubier Y, Puech AJ, Azcona A, Bailey PE, Lataste X. A randomised double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder. Psychopharmacology 1993;112:129-133.
42. 3 receptor antagonist. Fund Clin Pharmacol 1991;5:462.
43. 3 receptor mediated responses on NG108-15 cells and on the rat vague. Eur J Pharmacol 1992;219:135-140.
44. 3 receptors. Neuropharmacology 1993;32:729-735.
45. Prather PL, Rezazadeh SM, Lal H. Ondansetron-induced reversal of anxiogenic behaviours upon withdrawal from ethanol: Assessment by behavioural alterations in the elevated plus-maze. Soc Neurosci Abstr 1991;17:1419.
46. Prather PL, Rezazadeh SM, Lane JD, et al. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal. J Pharmacol Exp Ther 1993;264:622-630.
47. 3 receptors. Trends Neurosci 1986;9:424-428.
48. 3 receptor antagonist. Drug Dev Res 1992;28:18-10.
49. 4 receptor. Nauyn-Schmiedeberg's Arch Pharmacol 1992;346:498-503.
50. 3 receptor antagonism by BRL-43694 (granisetron). Eur J Pharmacol 1989;159:113-124.
51. 3 antagonist activity. Med Chem Res 1994;4:287-272.